Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Neuroblastoma

Here you will find summaries of a selection of ongoing clinical trials on neuroblastoma.

Trials with medicinal products

CRISP (tumors with ALK/MET/ROS1 abnormalities)  Clinical study of the safety and efficacy of the drug crizotinib in children, either alone or in combination with other drugs - open for inclusion

Durvalumab D419EC00001 (hematological/solid tumors)  Clinical study to evaluate the safety, tolerability and efficacy of durvalumab, or durvalumab in combination with tremelimumab, in young patients with advanced solid tumors or hematological malignancies - open for inclusion

ESMART (different tumor types)  Clinical study in children with cancer into the safety and efficacy of drugs matching a specific DNA alteration in the tumor - open for inclusion

INFORM2 NivEnt (various solid tumors)  Clinical study with nivolumab and entinostat in children and young adults with refractory cancer - open for inclusion

Ponatinib INCB084344 (leukemia/solid tumors)  Clinical study of the safety and efficacy of ponatinib for the treatment of different types of leukemia or solid tumors in children - open for inclusion

Venetoclax M13-833 (hematologic/solid tumors)  Clinical study of the safety and efficacy of the drug venetoclax in children and young adults - open for inclusion

Other trials

PINOCCHIO (multiple types of cancer)  Clinical study in children on the metabolism, distribution and excretion of chemotherapy in the body, also called pharmacokinetics - open for inclusion